Showing results (71-80 of 359) with videos related to
Sort By:
Pageof 36
The British Journal of Clinical Psychology|July 12, 2001
Recall bias, pain, depression and cost in back pain patientsT Pincus, S NewmanArthritis and Rheumatism|March 27, 2001
A randomized two-year study of the effects of dynamic strength training on muscle strength, disease activity, functional capacity, and bone mineral density in early rheumatoid arthritisA Häkkinen, T Sokka, A Kotaniemi, et al.The Journal of Rheumatology|August 18, 1999
Work disability in rheumatoid arthritis 10 years after the diagnosisT Sokka, H Kautiainen, T Möttönen, et al.Annals of the Rheumatic Diseases|February 21, 2003
Does yttrium radiosynovectomy increase the risk of cancer in patients with rheumatoid arthritis?J Vuorela, T Sokka, E Pukkala, et al.Annals of the Rheumatic Diseases|April 15, 2004
Similar prediction of mortality by the health assessment questionnaire in patients with rheumatoid arthritis and the general populationT Sokka, A Häkkinen, E Krishnan, et al.Current Allergy and Asthma Reports|June 7, 2003
Conjunctival allergen challenge: models in the investigation of ocular allergyMark B Abelson, Oliver LoefflerEuropean Journal of Ophthalmology|April 1, 1994
Levocabastine eye drops: a new approach for the treatment of acute allergic conjunctivitisM B Abelson, D WeintraubClinical Therapeutics|July 11, 2003
A randomized, double-blind, parallel-group comparison of olopatadine 0.1% ophthalmic solution versus placebo for controlling the signs and symptoms of seasonal allergic conjunctivitis and rhinoconjunctivitisMark B Abelson, Darell TurnerClinical Therapeutics|December 12, 2003
Double-masked, randomized, placebo-controlled clinical study of the mast cell-stabilizing effects of treatment with olopatadine in the conjunctival allergen challenge model in humansAndrea Leonardi, Mark B AbelsonSurvey of Ophthalmology|July 1, 1993
Conjunctivitis of allergic origin: immunologic mechanisms and current approaches to therapyM B Abelson, K SchaeferPageof 36